Clinical Review

How to choose the right vaginal moisturizer or lubricant for your patient

Author and Disclosure Information

 

References

Common concerns to be aware of

Women using vaginal products may be concerned about adverse effects, such as worsening vaginal irritation or infection. Vaginal moisturizers have not been shown to have increased risk of adverse effects compared with vaginal estrogens.9,10 In vitro studies have shown that vaginal moisturizers and lubricants inhibit the growth of Escherichia coli but may also inhibit Lactobacillus crispatus.24 Clinically, vaginal moisturizers have been shown to improve signs of bacterial vaginosis and have even been used to treat bacterial vaginosis.25,26 A study of commercially available vaginal lubricants inhibited the growth of L crispatus, which may predispose to irritation and infection.27 Nonetheless, the effect of the vaginal products on the vaginal microbiome and vaginal tissue remains poorly studied. Vaginal moisturizers and lubricants, while often helpful for patients, also can potentially cause irritation or predispose to infections. Providers should consider this when evaluating patients for new onset vaginal symptoms after starting vaginal products.

Bottom line

Vaginal products such as moisturizers and lubricants are often effective treatment options for women suffering from genitourinary syndrome of menopause and may be first-line treatment options, especially for women who may wish to avoid estrogen-containing products. Vaginal moisturizers can be recommended to any women experiencing vaginal irritation due to vaginal dryness while vaginal lubricants should be recommended to sexually active women who experience dyspareunia. Clinicians need to be aware of the formulations of these products and possible side effects in order to appropriately counsel patients. ●

Pages

Recommended Reading

Pregnancy increases risk for symptomatic kidney stones
MDedge ObGyn
For cervical cancer screening, any strategy is acceptable
MDedge ObGyn
FDA and power morcellation, gel for vaginal odor, and an intrauterine electrosurgery system
MDedge ObGyn
Stop checking routine lipid panels every year
MDedge ObGyn
2021 Update on cervical disease
MDedge ObGyn
Addressing an uncharted front in the war on COVID-19: Vaccination during pregnancy
MDedge ObGyn
FDA approves ibrexafungerp for vaginal yeast infection
MDedge ObGyn
Air pollution linked to increased fibroid risk in Black women
MDedge ObGyn
Pilot study: Hybrid laser found effective for treating genitourinary syndrome of menopause
MDedge ObGyn
Adverse pregnancy outcomes and later cardiovascular disease
MDedge ObGyn